Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Front and side images of the computer-aided design of the prostheses, including an interior perspective showing the location and size of the holes. by Long Li (6555)

Learn!Bio longitudinal, cross-sectional study 2020-2023: Cohort sizes and participants – overview. by Katy Andrews (22311170)

Subjects:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Analysis of Significantly Different Bacteria. by Xu Jia (187142)

Adjustment step size. by Qingnan Ji (22662198)

“…Integration efficiency increases by 18.7%, and computational complexity is significantly reduced, with average computation time decreased by 15.4%. …”

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Subjects:

Soil partice-size distribution. by Yonggang Huang (223155)

Effect of sample size on reproducibility. by Jan Willem Koten (17743224)

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

Curve of data size vs. running time. by Qingnan Ji (22662198)

“…Integration efficiency increases by 18.7%, and computational complexity is significantly reduced, with average computation time decreased by 15.4%. …”

Sample size characteristics. by Alex Bawuah (21702688)

“…The lack of birthweight data is a significant challenge in monitoring the global prevalence of extreme birthweight, either low or high, and newborn health. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

Significant condition. by Junxia Zhou (14381598)

Subjects:

Location, timing, and size of the European outbreaks. by Albertus Constantijn Sloof (20405090)

Sample size and span size diagram. by Wen Wang (6570)